v3.26.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
CURRENT ASSETS:    
Cash and cash equivalents $ 14,591 $ 16,232
R&D tax credit incentive receivable 305 654
Prepaid expenses and other current assets 937 1,012
Total current assets 15,833 17,898
Property and equipment, net 2,763 2,879
Operating lease right-of-use assets, net 15,713 17,230
Restricted cash 892 1,338
Deposits and other assets 109 48
TOTAL ASSETS 35,310 39,393
CURRENT LIABILITIES:    
Accounts payable 1,210 1,032
Accrued expenses 1,361 1,736
Litigation accrual 1,790 1,675
Accrued compensation expense 319 365
Lease liability, current portion 1,905 1,794
Total current liabilities 6,585 6,602
Lease liability, noncurrent portion 15,507 17,061
TOTAL LIABILITIES 22,092 23,663
Commitments and contingencies (Note 12)
STOCKHOLDERS' EQUITY:    
Common stock, par value $0.0001 per share; 300,000 shares authorized; shares issued and outstanding: 90,300 and 76,428 at September 30, 2026 and December 31, 2025, respectively 9 8
Additional paid-in capital 182,110 164,225
Accumulated other comprehensive income 32 30
Accumulated deficit (168,933) (148,533)
TOTAL STOCKHOLDERS' EQUITY 13,218 15,730
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 35,310 $ 39,393